# OnCo record william-wierda (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/william-wierda/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "william-wierda" ;
  schema:name "William G. Wierda"@en ;
  schema:description "Led CAPTIVATE, which established fixed-duration ibrutinib plus venetoclax as a first-line option for CLL."@en ;
  schema:url <https://onco.cc/people/william-wierda/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/?term=Wierda%20WG%5BAuthor%5D%20chronic%20lymphocytic%20leukemia> ;
  onco:tag "cll", "fixed-duration", "guidelines" ;
  schema:jobTitle "Professor and Section Chief of CLL, Department of Leukemia, MD Anderson Cancer Center" ;
  schema:sameAs <https://orcid.org/0000-0002-7357-270X> ;
  onco:cancers <https://onco.cc/cancers/cll/> ;
  onco:technologies <https://onco.cc/technologies/mrd-testing/>, <https://onco.cc/technologies/kinase-inhibitors/> ;
  onco:targets <https://onco.cc/targets/bcl2/> ;
  onco:drugs <https://onco.cc/drugs/venetoclax/> ;
  onco:institutions <https://onco.cc/institutions/md-anderson/> ;
  onco:trials <https://onco.cc/trials/captivate/> ;
  schema:affiliation <https://onco.cc/institutions/md-anderson/> .